Prevalence of sarcopenia and associated factors in patients in hemodialysis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Revista Ciências em Saúde |
Texto Completo: | https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153 |
Resumo: | Objective: To assess the prevalence of sarcopenia and associated factors in patients with chronic kidney disease (CKD) undergoing hemodialysis (HD). Methods: This cross-sectional study evaluated patients with CKD undergoing HD from January to October 2016 in two dialysis centers located in Recife, Pernambuco. For the diagnosis of sarcopenia, the criteria proposed by the 2019 European Consensus on Sarcopenia, which advocates low muscle strength as the main criterion, were considered. Demographic, clinical, anthropometric, and behavioral covariates were evaluated. Results: 108 patients were included, with a mean age of 51.4 ± 17.0 years and homogeneous distribution between the sexes.Sarcopenia was present in 38.9% of the population, of which 69% had severe sarcopenia. A higher prevalence of sarcopenia was observed among men (60% vs. 17%; p < 0.001), in those without a partner (48.1% vs. 30.4%; p < 0.045), in smokers (50% vs. 30%; p < 0.034), with low weight (underweight 73.3%, eutrophic 33.9%, overweight 32.4%; p = 0.001) and those with normal albumin levels (47.5% vs. 28.6%; p = 0.045). Conclusion: Approximately one in three nephropathic patients on hemodialysis presented sarcopenia and, among these, most had the severe form of this condition.Uremic sarcopenia was more prevalent in males, in individuals without partners, underweight, in smokers, and among those with normal albumin levels. |
id |
RCS_9e55ef9f86e2d2494ba5c9a0ff4df4f7 |
---|---|
oai_identifier_str |
oai:ojs.portalrcs.hcitajuba.org.br:article/1153 |
network_acronym_str |
RCS |
network_name_str |
Revista Ciências em Saúde |
repository_id_str |
|
spelling |
Prevalence of sarcopenia and associated factors in patients in hemodialysisPrevalência de sarcopenia e fatores associados em pacientes em hemodiálisechronic renal insufficiencyhemodialysessarcopeniahemodiáliseinsuficiência renal crônicasarcopeniaObjective: To assess the prevalence of sarcopenia and associated factors in patients with chronic kidney disease (CKD) undergoing hemodialysis (HD). Methods: This cross-sectional study evaluated patients with CKD undergoing HD from January to October 2016 in two dialysis centers located in Recife, Pernambuco. For the diagnosis of sarcopenia, the criteria proposed by the 2019 European Consensus on Sarcopenia, which advocates low muscle strength as the main criterion, were considered. Demographic, clinical, anthropometric, and behavioral covariates were evaluated. Results: 108 patients were included, with a mean age of 51.4 ± 17.0 years and homogeneous distribution between the sexes.Sarcopenia was present in 38.9% of the population, of which 69% had severe sarcopenia. A higher prevalence of sarcopenia was observed among men (60% vs. 17%; p < 0.001), in those without a partner (48.1% vs. 30.4%; p < 0.045), in smokers (50% vs. 30%; p < 0.034), with low weight (underweight 73.3%, eutrophic 33.9%, overweight 32.4%; p = 0.001) and those with normal albumin levels (47.5% vs. 28.6%; p = 0.045). Conclusion: Approximately one in three nephropathic patients on hemodialysis presented sarcopenia and, among these, most had the severe form of this condition.Uremic sarcopenia was more prevalent in males, in individuals without partners, underweight, in smokers, and among those with normal albumin levels.Objetivo: avaliar a prevalência de sarcopenia e os fatores associados em pacientes com doença renal crônica (DRC) em hemodiálise (HD). Métodos: Estudo transversal que avaliou pacientes portadores de DRC em HD no período de janeiro a outubro de 2016 em dois centros de diálise situados em Recife, Pernambuco. Para o diagnóstico de sarcopenia, foram considerados os critérios propostos pelo Consenso Europeu de Sarcopenia de 2019, que preconiza a baixa força muscular como critério principal. Foram avaliadas covariáveisdemográficas, clínicas, antropométricas e comportamentais. Resultados: Foram incluídos 108 pacientes, com média de idade de 51,4 ± 17,0 anos e distribuição homogênea entre os sexos. A sarcopenia foi presente em 38,9% da população, dos quais 69% apresentavamsarcopenia grave. Maior prevalência de sarcopenia foi observada entre os homens (60% vs. 17%; p < 0,001), nos que não tinham companheiros (48,1% vs. 30,4%; p < 0,045), em tabagistas (50% vs. 30%; p < 0,034), com baixo peso (baixo peso 73,3%, eutróficos 33,9%, excesso de peso 32,4%; p = 0,001) e naqueles com níveis de albumina normais (47,5% vs. 28,6%; p = 0,045). Conclusão: Aproximadamente um em cada três pacientes nefropatas em terapia hemodialítica apresentaram sarcopenia e dentre estes, a maioria tinha a forma grave dessa condição. A sarcopenia urêmica foi mais prevalente no sexo masculino, nos indivíduos sem companheiros, baixo peso, nos tabagistas e entre aqueles com níveis normais de albumina.AISI/HCI2021-12-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos parestextoinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/115310.21876/rcshci.v11i4.1153Revista Ciências em Saúde; v. 11 n. 4 (2021): Outubro a Dezembro de 2021; 61-69Health Sciences Journal; Vol 11 No 4 (2021): October to December 2021; 61-692236-378510.21876/rcshci.v11i4reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIengporhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153/765https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153/766Copyright (c) 2021 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessNunes, Camila FerreiraCarvalho, Tuane Rodrigues deDuarte, Ricardo da SilvaBarboza, Ylka Anny Couto OliveiraLemos, Maria Conceição Chaves dePinho, Claudia Porto Sabino2021-12-29T22:19:04Zoai:ojs.portalrcs.hcitajuba.org.br:article/1153Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2021-12-29T22:19:04Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse |
dc.title.none.fl_str_mv |
Prevalence of sarcopenia and associated factors in patients in hemodialysis Prevalência de sarcopenia e fatores associados em pacientes em hemodiálise |
title |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
spellingShingle |
Prevalence of sarcopenia and associated factors in patients in hemodialysis Nunes, Camila Ferreira chronic renal insufficiency hemodialyses sarcopenia hemodiálise insuficiência renal crônica sarcopenia |
title_short |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
title_full |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
title_fullStr |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
title_full_unstemmed |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
title_sort |
Prevalence of sarcopenia and associated factors in patients in hemodialysis |
author |
Nunes, Camila Ferreira |
author_facet |
Nunes, Camila Ferreira Carvalho, Tuane Rodrigues de Duarte, Ricardo da Silva Barboza, Ylka Anny Couto Oliveira Lemos, Maria Conceição Chaves de Pinho, Claudia Porto Sabino |
author_role |
author |
author2 |
Carvalho, Tuane Rodrigues de Duarte, Ricardo da Silva Barboza, Ylka Anny Couto Oliveira Lemos, Maria Conceição Chaves de Pinho, Claudia Porto Sabino |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Nunes, Camila Ferreira Carvalho, Tuane Rodrigues de Duarte, Ricardo da Silva Barboza, Ylka Anny Couto Oliveira Lemos, Maria Conceição Chaves de Pinho, Claudia Porto Sabino |
dc.subject.por.fl_str_mv |
chronic renal insufficiency hemodialyses sarcopenia hemodiálise insuficiência renal crônica sarcopenia |
topic |
chronic renal insufficiency hemodialyses sarcopenia hemodiálise insuficiência renal crônica sarcopenia |
description |
Objective: To assess the prevalence of sarcopenia and associated factors in patients with chronic kidney disease (CKD) undergoing hemodialysis (HD). Methods: This cross-sectional study evaluated patients with CKD undergoing HD from January to October 2016 in two dialysis centers located in Recife, Pernambuco. For the diagnosis of sarcopenia, the criteria proposed by the 2019 European Consensus on Sarcopenia, which advocates low muscle strength as the main criterion, were considered. Demographic, clinical, anthropometric, and behavioral covariates were evaluated. Results: 108 patients were included, with a mean age of 51.4 ± 17.0 years and homogeneous distribution between the sexes.Sarcopenia was present in 38.9% of the population, of which 69% had severe sarcopenia. A higher prevalence of sarcopenia was observed among men (60% vs. 17%; p < 0.001), in those without a partner (48.1% vs. 30.4%; p < 0.045), in smokers (50% vs. 30%; p < 0.034), with low weight (underweight 73.3%, eutrophic 33.9%, overweight 32.4%; p = 0.001) and those with normal albumin levels (47.5% vs. 28.6%; p = 0.045). Conclusion: Approximately one in three nephropathic patients on hemodialysis presented sarcopenia and, among these, most had the severe form of this condition.Uremic sarcopenia was more prevalent in males, in individuals without partners, underweight, in smokers, and among those with normal albumin levels. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer reviewed Avaliado pelos pares texto info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153 10.21876/rcshci.v11i4.1153 |
url |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153 |
identifier_str_mv |
10.21876/rcshci.v11i4.1153 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153/765 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153/766 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
AISI/HCI |
publisher.none.fl_str_mv |
AISI/HCI |
dc.source.none.fl_str_mv |
Revista Ciências em Saúde; v. 11 n. 4 (2021): Outubro a Dezembro de 2021; 61-69 Health Sciences Journal; Vol 11 No 4 (2021): October to December 2021; 61-69 2236-3785 10.21876/rcshci.v11i4 reponame:Revista Ciências em Saúde instname:Hospital de Clínicas de Itajubá instacron:HCI |
instname_str |
Hospital de Clínicas de Itajubá |
instacron_str |
HCI |
institution |
HCI |
reponame_str |
Revista Ciências em Saúde |
collection |
Revista Ciências em Saúde |
repository.name.fl_str_mv |
Revista Ciências em Saúde - Hospital de Clínicas de Itajubá |
repository.mail.fl_str_mv |
rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br |
_version_ |
1797068963243360256 |